Rainbow Children's Medicare Limited has notified the stock exchanges of an earnings conference call scheduled for Monday, May 25, 2026, at 10:00 AM IST. The intimation, dated May 15, 2026, was filed by Company Secretary and Compliance Officer Shreya Mitra pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015. The call is intended to discuss the company's financial and operating performance for the quarter and financial year ended March 31, 2026.

Conference Call Details

The earnings call has been organised in association with IIFL and is open to investors and analysts. The following table summarises the key logistics of the event:

Management Participants

The conference call will feature participation from Rainbow Children's Medicare Limited's senior leadership team. The following key executives are scheduled to participate:

• Dr. Ramesh Kancharla – Chairman and MD
• Mr. Abrar Ali Dalal – Group Chief Executive Officer
• Mr. Vikas Maheshwari – Group Chief Financial Officer
• Mr. Saurabh Bhandari – Head IR & Business Intelligence

About the Filing

The regulatory intimation was submitted to both the National Stock Exchange of India Limited and BSE Limited on May 15, 2026. The filing was signed digitally by Shreya Mitra, Company Secretary and Compliance Officer of Rainbow Children's Medicare Limited, on the same date. The company's registered office is located at 8-2-120/103/1, Survey No. 403, Road No. 2, Banjara Hills, Hyderabad, Telangana - 500034, with operations spanning multiple cities including Hyderabad, Vijayawada, Chennai, Bengaluru, Delhi, and Visakhapatnam.

Rainbow Children's Medicare Limited has informed the stock exchanges of an upcoming Board of Directors meeting, pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting is scheduled to be held on Saturday, May 23, 2026, and will take up key financial and corporate agenda items for the concluded fiscal year.

Board Meeting Agenda

The Board meeting has been convened to address the following key matters:

• Approval of Audited Financial Results: The Board will consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the Quarter and Financial Year ended March 31, 2026.
• Final Dividend Recommendation: The Board will also consider recommending a Final Dividend, if any, on the Equity Shares of the Company for the Financial Year ended March 31, 2026.

The following table summarises the key details of the scheduled board meeting:

Trading Window Closure

In continuation of the company's letter dated March 25, 2026, and in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code for Prevention of Insider Trading, the Trading Window for dealing in the securities of Rainbow Children's Medicare Limited is currently closed. The Trading Window shall reopen 48 hours after the declaration of the aforementioned financial results.

The intimation was signed by Shreya Mitra, Company Secretary and Compliance Officer, on May 15, 2026. The company's registered office is located at 8-2-120/103/1, Survey No. 403, Road No. 2, Banjara Hills, Hyderabad, Telangana - 500034.